Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition: Advanced Malignant Solid Tumors Intervention: Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors: Stemirna Therapeutics; Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition: Advanced Malignant Solid Tumors Intervention: Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors: Stemirna Therapeutics; Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition: Advanced Malignant Solid Tumors Intervention: Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors: Stemirna Therapeutics; Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition: Advanced Malignant Solid Tumors Intervention: Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors: Stemirna Therapeutics; Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition: Advanced Malignant Solid Tumors Intervention: Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors: Stemirna Therapeutics; Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition: Advanced Malignant Solid Tumors Intervention: Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors: Stemirna Therapeutics; Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions: NSCLC Stage IV; ALK Fusion Protein Expression Intervention: Biological: Peptide vaccine Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials